Print Page  Close Window

Investors

OraSure Technologies develops, manufactures and markets oral fluid specimen collection devices using proprietary oral fluid technologies, diagnostic products including immunoassays and other in vitro diagnostic tests, and other medical devices. These products are sold in the United States as well as internationally to various clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians’ offices, and commercial and industrial entities.
More>>
Featured Reports
2017 Annual Report on Form 10-K - PDF 2017 Annual Report on Form 10-K
Fact Sheet - PDF Fact Sheet
OSUR (Common Stock)
ExchangeNASDAQ (US Dollar)
Price$17.44
Change (%) Stock is Down 0.3 (1.69%)
Volume48,093
Data as of 04/19/18 11:24 a.m. ET
Minimum 20 minute delay
Refresh quote
Recent NewsMore >>
DateTitle 
04/11/18OraSure Technologies Earnings Conference Call Invitation
2018 First Quarter Earnings Conference Call Wednesday, May 2, 2018, 5:00 p.m. ET BETHLEHEM, Pa., April 11, 2018 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR) has scheduled its regular earnings conference call covering 2018 First quarter financial results, 2018 second quarter financial guidance and certain business developments for 5:00 pm ET (2:00 pm PT) on Wednesday, May 2, 2018.  May 2, 2018 Schedule 4:00 p.m. ET   2018 first quarter financial resul... 
Printer Friendly Version
04/10/18OraSure Technologies Appoints New Senior Vice President, Business Development
BETHLEHEM, Pa., April 10, 2018 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point of care diagnostic tests and specimen collection devices, today announced that David Rappaport has been appointed as the Company’s new Senior Vice President, Business Development. Prior to joining OraSure, Mr. Rappaport served as Senior Vice President, Healthcare Investment Banking at Raymond James & Associates where he provided investment banking services in the Life Sciences ... 
Printer Friendly Version
02/26/18OraSure Technologies to Present at the Raymond James 39th Annual Institutional Investors Conference
BETHLEHEM, Pa., Feb. 26, 2018 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point of care diagnostic tests and specimen collection devices, today announced that Douglas A. Michels, President and CEO, will speak to the investment community at the Raymond James 39th Annual Institutional Investors Conference.  The conference will be simultaneously webcast over the Internet. Mr. Michels is scheduled to speak on March 5, 2018, at approximately 10:25 AM Eastern Time (7... 
Printer Friendly Version
02/08/18OraSure Technologies to Present at the LEERINK 7th Annual Global Healthcare Conference
BETHLEHEM, Pa., Feb. 08, 2018 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point of care diagnostic tests and specimen collection devices, today announced that Douglas A. Michels, President and CEO, will speak to the investment community at the LEERINK 7th Annual Global Healthcare Conference.  The conference will be simultaneously webcast over the Internet. Mr. Michels is scheduled to speak on February 14, 2018, at approximately 3:30 pm Eastern Time (12:30 pm Pa... 
Printer Friendly Version
Upcoming EventsMore >>
DateTitle
05/02/18 5:00 p.m. ET
Q1 2018 OraSure Technologies, Inc. Earnings Conference Call
05/08/18 10:00 a.m. ET
OraSure Technologies, Inc. 2018 Annual Meeting of Stockholders
Data provided by Nasdaq. Minimum 15 minutes delayed. View Attributions and Sources